Form 4: Aterian CFO Joshua Feldman Reports Significant Stock Transactions, Including Grant and Tax-Related Sales

Aterian, Inc.'s Chief Financial Officer, Joshua Feldman, reported the acquisition of 248,049 restricted common shares and subsequent sales of 16,576 shares for tax purposes.

Summary

• Joshua Feldman, Chief Financial Officer of Aterian, Inc., reported changes in his beneficial ownership of the company's common stock.
• On June 11, 2025, Mr. Feldman acquired 248,049 shares of restricted common stock at a price of $1.39 per share. These shares were granted pursuant to the Issuer's 2018 Equity Incentive Plan and are subject to vesting.
• Following this acquisition, Mr. Feldman's beneficial ownership of Aterian common stock was 394,018 shares.
• On June 12, 2025, Mr. Feldman sold 15,322 shares of common stock at a weighted average price of $1.32 per share. The sales occurred within a price range of $1.32 to $1.37, inclusive.
• On June 13, 2025, he sold an additional 1,254 shares of common stock at a weighted average price of $1.23 per share. These sales occurred within a price range of $1.22 to $1.23, inclusive.
• Both sales transactions were explicitly stated to be for tax-related purposes.
• After all reported transactions, Mr. Feldman's direct beneficial ownership of Aterian common stock stands at 377,442 shares.
• All reported transactions were made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The sales, while reducing direct ownership, are explicitly for tax purposes and follow a substantial grant of restricted stock, indicating continued incentive alignment. The transactions are routine for an insider and were conducted under a pre-planned Rule 10b5-1 arrangement.

Positives

• The grant of 248,049 shares of restricted common stock to the CFO aligns his incentives with the company's long-term performance and shareholder value.
• The transactions were conducted under a Rule 10b5-1(c) plan, indicating pre-planned and systematic trading rather than reactive or opportunistic sales.

Negatives

• The Chief Financial Officer sold a total of 16,576 shares of common stock, which reduces his direct ownership in the company.
• The sale prices ($1.32 and $1.23 weighted average) were lower than the acquisition price of the restricted stock grant ($1.39).

Future Outlook

This SEC Form 4 filing details insider stock transactions and does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This Form 4 filing reports routine insider stock transactions for Aterian, Inc.'s Chief Financial Officer. It does not provide broader industry context or trends, as its primary purpose is to disclose changes in beneficial ownership by company insiders.

Related Party Transactions

• The transactions involve the company's Chief Financial Officer, Joshua Feldman, acquiring and disposing of company stock, which are standard related-party transactions under equity compensation plans.

Stakeholder Impact

• Shareholders: The filing provides transparency regarding insider stock activity. The grant of restricted stock aligns the CFO's interests with shareholders, while the tax-related sales are a common occurrence and generally not indicative of a lack of confidence.

Next Steps

• The restricted common stock granted to Joshua Feldman is subject to vesting, implying future milestones related to the vesting schedule.

Key Dates

Recommendation

Keywords

Aterian Inc., ATER, SEC Form 4, Insider Trading, Stock Grant, Stock Sale, Restricted Stock, Chief Financial Officer, Joshua Feldman, Equity Incentive Plan, Rule 10b5-1